These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Psychosis following treatment with topiramate]. Verhoeven WM; Boermans JA; van der Heijden FM; Tuinier S Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2093-5. PubMed ID: 12448965 [TBL] [Abstract][Full Text] [Related]
4. Topiramate-induced psychosis: the picture at 12 months. Watkin A; Alam F; Javed Q BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22791731 [TBL] [Abstract][Full Text] [Related]
5. The importance of being seizure free: topiramate and psychopathology in epilepsy. Mula M; Trimble MR Epilepsy Behav; 2003 Aug; 4(4):430-4. PubMed ID: 12899865 [TBL] [Abstract][Full Text] [Related]
6. Topiramate and psychiatric adverse events in patients with epilepsy. Mula M; Trimble MR; Lhatoo SD; Sander JW Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464 [TBL] [Abstract][Full Text] [Related]
7. [Psychosis with topiramate]. García Cabeza I; Gutiérrez Rodríguez M; Epifanio Gutiérrez MM Actas Esp Psiquiatr; 2000; 28(3):202-4. PubMed ID: 11000703 [TBL] [Abstract][Full Text] [Related]
8. Auditory hallucinations associated with topiramate. Matthews SC; Miller BP J Clin Psychiatry; 2001 Aug; 62(8):653. PubMed ID: 11561939 [No Abstract] [Full Text] [Related]
9. [Psychosis following treatment with topiramate]. Voskuil PH Ned Tijdschr Geneeskd; 2003 Feb; 147(7):319-20; author reply 320. PubMed ID: 12622013 [No Abstract] [Full Text] [Related]
10. Timing and clinical characteristics of topiramate-induced psychosis in a patient with epilepsy and tuberous sclerosis. Pasini A; Pitzianti M; Baratta A; Moavero R; Curatolo P Clin Neuropharmacol; 2014; 37(1):38-9. PubMed ID: 24434533 [TBL] [Abstract][Full Text] [Related]
11. Reversible hemiparesis associated with the use of topiramate. Patel H; Asconapé JJ; Garg BP Seizure; 2002 Oct; 11(7):460-3. PubMed ID: 12237075 [TBL] [Abstract][Full Text] [Related]
12. An audit of topiramate use in a general neurology clinic. Crawford P Seizure; 1998 Jun; 7(3):207-11. PubMed ID: 9700833 [TBL] [Abstract][Full Text] [Related]
13. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389 [TBL] [Abstract][Full Text] [Related]
14. Topiramate-induced myoclonus and psychosis during migraine prophylaxis. Miller AD; Prost VM; Bookstaver PB; Gaines KJ Am J Health Syst Pharm; 2010 Jul; 67(14):1178-80. PubMed ID: 20592323 [TBL] [Abstract][Full Text] [Related]
15. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Trimble MR; Rüsch N; Betts T; Crawford PM Seizure; 2000 Jun; 9(4):249-54. PubMed ID: 10880283 [TBL] [Abstract][Full Text] [Related]
17. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Mula M; Trimble MR; Sander JW Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462 [TBL] [Abstract][Full Text] [Related]
18. Antiepileptic-induced Psychosis as a Possible Predictor of Post-temporal Lobectomy Alternative Psychosis. Benedict F; Lim KS; Jambunathan ST; Hashim AH East Asian Arch Psychiatry; 2016 Sep; 26(3):109-11. PubMed ID: 27703099 [TBL] [Abstract][Full Text] [Related]
19. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both? Latour P; Biraben A; Polard E; Bentué-Ferrer D; Beauplet A; Tribut O; Allain H Hum Psychopharmacol; 2004 Apr; 19(3):193-203. PubMed ID: 15079854 [TBL] [Abstract][Full Text] [Related]
20. Topiramate-induced metabolic acidosis: report of two cases. Ko CH; Kong CK Dev Med Child Neurol; 2001 Oct; 43(10):701-4. PubMed ID: 11665828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]